ARCHIVES

PCORI Approves $54.8 Million For Clinical Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011

In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH

October 4, 1974

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010